Together we will beat cancer


Ovarian cancer is the 6th most common cancer in women in the UK, with 7,400 people diagnosed each year. The symptoms of ovarian cancer can be very vague, particularly when the disease is in its early stages.

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.

Read More

Building tumours in the lab – a how to guide

Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments.

Read More

Ovarian cancer screening trial – a tantalising result?

We look at the long-awaited results from a study testing whether an ovarian cancer screening programme could actually save lives from the disease.

Read More

No, HRT isn’t ‘harmless’ – there are risks as well as benefits

Yesterday saw some bold, but extremely misleading headlines about hormone replacement therapy (HRT) being “harmless”. This unfortunate statement flies in…

Read More

Our milestones: Cisplatin – the story of a platinum-selling life-saver

This entry is part 23 of 30 in the series Our milestones

In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.

Read More

Cancer survival in England is improving – but still lagging behind similar countries

We explore new data showing that cancer survival in England remains lower than countries with similar healthcare systems.

Read More

Shape-shifting molecular cousins are the key to DNA repair

It’s taken years of frustration and dedication (not to mention countless hours spent in a small room roughly the temperature…

Read More

Cancer killer combination could make cells more sensitive to chemo

How our researchers in Manchester are helping develop ways to make chemotherapy kinder and more effective.

Read More

A disappointing decision over olaparib for ovarian cancer

In light of a preliminary ‘no’ from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug’s development

Read More

New ovarian cancer blood test is promising – but screening still a way off

We look at headlines about a new blood test for ovarian cancer, and why a possible routine screening test for the disease is still some way off.

Read More